Let-7 miRNA-binding site polymorphism in the KRAS 3′UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/− cetuximab
© Kjersem et al.; licensee BioMed Central Ltd. 2012
Received: 24 July 2012
Accepted: 14 November 2012
Published: 20 November 2012
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting firstname.lastname@example.org.
|24 Jul 2012||Submitted||Original manuscript|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|1 Aug 2012||Reviewed||Reviewer Report - Martin Pichler|
|7 Sep 2012||Reviewed||Reviewer Report - Joanne Weidhaas|
|12 Oct 2012||Author responded||Author comments - Janne Beathe Kjersem|
|Resubmission - Version 3|
|12 Oct 2012||Submitted||Manuscript version 3|
|15 Oct 2012||Author responded||Author comments - Janne Beathe Kjersem|
|Resubmission - Version 4|
|15 Oct 2012||Submitted||Manuscript version 4|
|Resubmission - Version 5|
|Submitted||Manuscript version 5|
|15 Oct 2012||Reviewed||Reviewer Report - Martin Pichler|
|7 Nov 2012||Reviewed||Reviewer Report - Joanne Weidhaas|
|Resubmission - Version 6|
|Submitted||Manuscript version 6|
|14 Nov 2012||Editorially accepted|
|20 Nov 2012||Article published||10.1186/1471-2407-12-534|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting email@example.com. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.